PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34352502-0	2022	Synthesis of gold nanoparticles@reduced porous graphene-modified ITO electrode for spectroelectrochemical detection of SARS-CoV-2 spike protein.	Graphite	47-55	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	130-135	
33748577-7	2021	The low limit of detection (125 copies/mL for the influenza virus and 1 fg/mL for the recombinant 2019-nCoV spike protein) has demonstrated the sensitivity of the MXene-graphene VSTM on the FET platform to virus sensing.	Graphite	169-177	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	108-113	
32293168-5	2020	The sensor was produced by coating graphene sheets of the FET with a specific antibody against SARS-CoV-2 spike protein.	Graphite	35-43	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	106-111	
33105999-7	2020	In the case of adsorption onto graphite, the initial adsorption configuration is not stable and the surface induces a substantial deformation of the glycoprotein spike with a large number of adsorbed residues not pertaining to the binding subunits of the spike monomers.	Graphite	31-39	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	162-167	
33105999-7	2020	In the case of adsorption onto graphite, the initial adsorption configuration is not stable and the surface induces a substantial deformation of the glycoprotein spike with a large number of adsorbed residues not pertaining to the binding subunits of the spike monomers.	Graphite	31-39	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	255-260	
34485782-0	2021	Structural Behavior of Monomer of SARS-CoV-2 Spike Protein during Initial Stage of Adsorption on Graphene.	Graphite	97-105	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	45-50	
34356205-9	2021	The advancements in sensing platforms have amplified the detection levels and provided real-time results for SARS-CoV-2 spike protein detection with limits as low as 1 fg/mL in the Graphene Field Effect Transistor (FET) sensor.	Graphite	181-189	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	120-125	
34834039-0	2021	Ultrasensitive Detection of COVID-19 Causative Virus (SARS-CoV-2) Spike Protein Using Laser Induced Graphene Field-Effect Transistor.	Graphite	100-108	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	66-71	
34476766-5	2022	Additionally, the possible interaction of two-dimensional (2D) nanomaterials, including graphene, bismuthene, phosphorene, p-doped graphene, and functionalized p-doped graphene, with spike protein is investigated.	Graphite	168-176	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	183-188	
34128653-0	2021	COVID-19 Spike Protein Induced Phononic Modification in Antibody-Coupled Graphene for Viral Detection Application.	Graphite	73-81	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	9-14	
34128653-2	2021	Here, we report on the modification of the dopant density and the phononic energy of antibody-coupled graphene when it interfaces with SARS-CoV-2 spike protein.	Graphite	102-110	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	146-151	
34128653-3	2021	This graphene chemeo-phononic system was able to detect SARS-CoV-2 spike protein at the limit of detection of ~3.75 and ~1 fg/mL in artificial saliva and phosphate-buffered saline, respectively.	Graphite	5-13	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	67-72	
35538925-1	2022	The biofunctionalization of graphene field-effect transistors (GFETs) through vinylsulfonated-polyethyleneimine nanoscaffold is presented for enhanced biosensing of severe acute respiratory-related coronavirus 2 (SARS-CoV-2) spike protein and human ferritin, two targets of great importance for the rapid diagnostic and monitoring of individuals with COVID-19.	Graphite	28-36	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	225-230	
35252734-0	2022	Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots.	Graphite	208-216	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	46-51	
35252734-3	2022	Herein, we report for the first time that human host defense neutrophil alpha-defensin HNP1 and human cathelicidin LL-37 peptide-conjugated graphene quantum dots (GQDs) have the capability to prevent the delta variant virus entry into the host cells via blocking SARS-CoV-2 delta variant (B.1.617.2) spike protein receptor-binding domain (RBD) binding with host cells" angiotensin converting enzyme 2 (ACE2).	Graphite	140-148	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	300-305